Cargando…
Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
BACKGROUND: Bilastine is a safe and effective commonly prescribed non-sedating H(1)-antihistamine approved for symptomatic treatment in patients with allergic disorders such as rhinoconjunctivitis and urticaria. It was evaluated in many patients throughout the clinical development required for its a...
Autores principales: | Leceta, Amalia, Sologuren, Ander, Valiente, Román, Campo, Cristina, Labeaga, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Just Medical Media Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299972/ https://www.ncbi.nlm.nih.gov/pubmed/28210286 http://dx.doi.org/10.7573/dic.212500 |
Ejemplares similares
-
Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022) -
Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020) -
Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions
por: Leceta, Amalia, et al.
Publicado: (2021) -
Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013) -
Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)